前列腺癌单次消融放疗中盆腔亚结构剂量与泌尿及性功能损伤的关联:ABRUPT 试验事后分析
该研究对 ABRUPT 试验(NCT04831983)中 30 例局限期前列腺癌患者进行事后分析,勾画膀胱三角、泌尿生殖膈、神经血管束等功能亚结构并提取剂量参数。结果显示晚期泌尿功能障碍与膀胱三角 D1cc ≥ 20.3 Gy 相关,勃起功能障碍与神经血管束 D0.035 cc ≥ 23.6 Gy 存在提示性关联,但事件数有限。
要点
- 膀胱三角 D1cc ≥ 20.3 Gy 与晚期泌尿功能障碍相关,交叉验证 AUC 为 0.80。
- 神经血管束 D0.035 cc ≥ 23.6 Gy 与勃起功能障碍呈提示性关联,事件数有限。
- 膀胱体积 >166.8 cc 与患者报告的泌尿功能恶化相关(p=0.030)。
核心结论
- 本探索性分析提示膀胱三角可能是单次消融放疗后泌尿系统并发症的潜在预测因素。
- 将亚结构保护纳入治疗计划可能改善功能保留并减少晚期毒性,尚待更大规模前瞻性试验验证。
研究设计与样本
- 对前瞻性 ABRUPT 试验(NCT04831983)中 30 例局限期前列腺癌患者进行事后分析。
- 由经验丰富的放射肿瘤科医生勾画膀胱三角、泌尿生殖膈、神经血管束、阴茎球、阴部内动脉和阴茎脚等功能亚结构。
- 从计划剂量体积直方图提取最大剂量和平均剂量,采用 CTCAE 和患者报告结局评估不良事件。
- 使用逻辑回归、Wilcoxon-Mann-Whitney 检验和 ROC 分析探索剂量-毒性关联及预测阈值,并进行交叉验证。
主要发现
- 晚期泌尿功能障碍与膀胱三角 D1cc ≥ 20.3 Gy 相关(交叉验证 AUC=0.80;PPV=64.3%;NPV=75.0%),在医生报告和患者报告终点中一致。
- 膀胱体积 >166.8 cc 与患者报告的泌尿功能恶化相关(p=0.030)。
- 在 29 例中 22 例(76%)睾酮恢复(ADT 完成后中位 10 个月)的患者中,勃起功能障碍与神经血管束 D0.035 cc ≥ 23.6 Gy 呈提示性关联(表观 AUC=0.98),但基于有限的事件数。
- 性功能障碍患者中观察到阴部内动脉和阴茎脚剂量较高的趋势,而阴茎球剂量未见关系。
关键数值与推荐
- 膀胱三角 D1cc ≥ 20.3 Gy:交叉验证 AUC=0.80,PPV=64.3%,NPV=75.0%,与晚期泌尿功能障碍相关。
- 膀胱体积 >166.8 cc:与患者报告泌尿功能恶化相关,p=0.030。
- 神经血管束 D0.035 cc ≥ 23.6 Gy:表观 AUC=0.98,与勃起功能障碍呈提示性关联(事件数有限)。
临床怎么用
- 在单次消融放疗计划中可考虑将膀胱三角作为剂量限制亚结构,以降低晚期泌尿毒性风险。
- 对神经血管束剂量的关注可能有助于性功能保留,但现有证据仅为提示性,需谨慎解读。
- 膀胱体积较大(>166.8 cc)的患者可能需关注泌尿功能恶化风险。
局限性
- 本研究为探索性事后分析,样本量仅 30 例,统计效能有限。
- 勃起功能障碍相关分析基于有限的事件数,结果需谨慎解读。
- 结论尚待更大规模前瞻性试验验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To investigate the association between radiation dose to pelvic functional substructures and the incidence of urinary and sexual side-effects following single-dose ablative radiotherapy (SDRT) for localized prostate cancer. METHODS AND MATERIALS: A post hoc analysis was conducted on the 30 patients from the prospective ABRUPT trial (NCT04831983). Functional substructures, including the bladder trigone, urogenital diaphragm, neurovascular bundles (NVB), penile bulb (PB), internal pudendal arteries (IPA), and crura, were contoured by an experienced radiation oncologist. Maximum and mean doses were extracted from planning dose-volume histograms. Adverse events (AEs) were assessed using CTCAE and patient-reported outcomes (PRO). Logistic regression, Wilcoxon-Mann-Whitney, and ROC analyses were used to explore dose-toxicity associations and predictive thresholds, with cross-validation for robustness. RESULTS: Late urinary dysfunction correlated with bladder trigone D1cc ≥ 20.3 Gy (cross-validated AUC = 0.80; PPV = 64.3%; NPV = 75.0%), consistent across physician- and patient-reported endpoints. Larger bladder volumes (>166.8 cc) were also associated with urinary PRO deterioration (p = 0.030). Among 22 patients (76% of 29) who recovered testosterone (median = 10 months post ADT completion), erectile dysfunction showed a suggestive association with NVB D0.035 cc ≥ 23.6 Gy (apparent AUC = 0.98), although based on a limited number of events. Trends toward higher IPA and crura doses were observed in patients with sexual dysfunction, while no relationship was observed for PB dose. CONCLUSIONS: This exploratory analysis highlights the bladder trigone as potential predictor of urinary morbidity in SDRT. Incorporating substructure-sparing into treatment planning could improve functional preservation and reduce late toxicity, pending prospective validation in larger trials.
引用
- Arcangeli S, Faccenda V, Ferrario F, et al. Association between dose to specific pelvic substructures and urinary and sexual dysfunction following Single-Dose ablative radiotherapy for prostate Cancer: A post hoc analysis from the ABRUPT trial. Clin Transl Radiat Oncol. 2026. PMID: 41732214. doi:10.1016/j.ctro.2026.101127
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。